EPIRUS Biopharmaceuticals Provides Clinical Program Update on BOW015 (Infliximab Biosimilar)
Go back to EPIRUS Biopharmaceuticals Provides Clinical Program Update on BOW015 (Infliximab Biosimilar)| Enterprise Informatics, Inc. (NASDAQ: EPRS) | Delayed: 0.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.14 | 52 Week High | $6.76 | |||
| Open | $0.00 | 52 Week Low | $0.08 | |||
| Day High | $0.14 | P/E | 14.00 | |||
| Day Low | $0.14 | EPS | $0.01 | |||
| Volume | 12,001 | |||||
